This app has been exclusively created for participants in the medical study for Lilly W8M-MC-LAA2. It contains Televisit functionality and allows participants to complete questionnaires.
W8M-MC-LAA2 is a Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management with LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants with Obesity or Overweight with T2D